
Multiple Myeloma Evolution: Cereblon E3 Ligase Modulators as Next-Generation Therapy in Relapsed/Refractory Disease
Wednesday, March 11, 2026
2:00 p.m. – 3:00 p.m. ET
Please note this TeleECHO program is 2:00 p.m. Eastern, 1:00 p.m. Central, 12:00 p.m. Mountain and 11:00 a.m. Pacific.